Bisolvine
- Product NDC
- 53145-322
- 11-digit product format
- 531450322
- Labeler code
- 53145
- Product ID
- 53145-322_3a8ae821-335c-8faf-e063-6394a90ab4bd
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Guaifenesin, Dextromethorphan
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- MENPER DISTRIBUTORS INC.
- Application
- M012
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2010-01-18
- Substance
- DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN
- Active strength
- 10; 100 mg/15mL; mg/15mL
- Pharmacologic classes
- Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Bisolvine
- Brand name suffix
- Children
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DEXTROMETHORPHAN HYDROBROMIDE | 10 mg/15mL |
| GUAIFENESIN | 100 mg/15mL |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 9D2RTI9KYH, 495W7451VQ |
| Rxcui | 1298228 |
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 53145-322-04 | BisolvineChildren | 1 in 1 CARTON | LIQUID | 1 | | 4 |
| 53145-322-04 | BisolvineChildren | 120 mL in 1 BOTTLE | LIQUID | 120 | | 4 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 53145-322-04 | 53145032204 | 1 BOTTLE in 1 CARTON (53145-322-04) / 120 mL in 1 BOTTLE | 1 bottle | 2010-01-18 | 0000-00-00 | No | No | Current |